Phenotypic drug discovery: recent successes, lessons learned and new directions

F Vincent, A Nueda, J Lee, M Schenone… - Nature Reviews Drug …, 2022 - nature.com
Many drugs, or their antecedents, were discovered through observation of their effects on
normal or disease physiology. For the past generation, this phenotypic drug discovery …

Animal models of human disease: challenges in enabling translation

P McGonigle, B Ruggeri - Biochemical pharmacology, 2014 - Elsevier
Animal models have historically played a critical role in the exploration and characterization
of disease pathophysiology, target identification, and in the in vivo evaluation of novel …

Integrated genomics and proteomics define huntingtin CAG length–dependent networks in mice

P Langfelder, JP Cantle, D Chatzopoulou… - Nature …, 2016 - nature.com
To gain insight into how mutant huntingtin (mHtt) CAG repeat length modifies Huntington's
disease (HD) pathogenesis, we profiled mRNA in over 600 brain and peripheral tissue …

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease

K Sathasivam, A Neueder, TA Gipson… - Proceedings of the …, 2013 - National Acad Sciences
Huntington disease (HD) is a devastating, late-onset, inherited neurodegenerative disorder
that manifests with personality changes, movement disorders, and cognitive decline. It is …

Molecular mechanisms and potential therapeutical targets in Huntington's disease

C Zuccato, M Valenza, E Cattaneo - Physiological reviews, 2010 - journals.physiology.org
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat
expansion in the gene encoding for huntingtin protein. A lot has been learned about this …

Calcium pumps in health and disease

M Brini, E Carafoli - Physiological reviews, 2009 - journals.physiology.org
Ca2+-ATPases (pumps) are key actors in the regulation of Ca2+ in eukaryotic cells and are
thus essential to the correct functioning of the cell machinery. They have high affinity for …

Long non-coding RNAs in Huntington's disease neurodegeneration

R Johnson - Neurobiology of disease, 2012 - Elsevier
Neurodegeneration in the brains of Huntington's disease patients is accompanied by
widespread changes in gene regulatory networks. Recent studies have found that these …

Huntington disease: pathogenesis and treatment

P Dayalu, RL Albin - Neurologic clinics, 2015 - neurologic.theclinics.com
Huntington disease (HD) is an autosomal dominant inherited neurodegenerative disease
characterized by progressive motor, behavioral, and cognitive decline, resulting in death …

[HTML][HTML] The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients

A Neueder, C Landles, R Ghosh, D Howland… - Scientific reports, 2017 - nature.com
We have previously shown that exon 1 of the huntingtin gene does not always splice to exon
2 resulting in the production of a small polyadenylated mRNA (HTTexon1) that encodes the …

Calcium signaling and neurodegenerative diseases

I Bezprozvanny - Trends in molecular medicine, 2009 - cell.com
Neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD),
amyotrophic lateral sclerosis (ALS), Huntington's disease (HD) and spinocerebellar ataxias …